At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 60 enrolled
Drug / intervention
CTGel/ BPO Wash +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 3B, Multicenter, Assessor-Blinded Study of the Tolerability of Clindamycin 1%-Tretinoin 0.025% Gel Used in Conjunction With Benzoyl Peroxide 4% Wash in Subjects With Mild to Moderate Facial Acne Vulgaris
In Brief
A Phase 3 clinical trial evaluating CTGel/ BPO Wash and Soap Free Cleanser and CTGel for Acne Vulgaris. Completed, enrolled 60 participants across 5 sites.
Detailed Summary
The purpose of this study is to evaluate the tolerability of a combined regimen of a topical antibiotic and retinoid and a benzoyl peroxide wash.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
CollaboratorsGlaxoSmithKline
Timeline
Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2009
First PostedMay 2009
Primary CompletionJun 2009
Study CompletionJun 2009
TodayJul 2026
First PostedMay 1, 2009
Enrollment StartApr 1, 2009
Primary CompletionJun 1, 2009
Study CompletionJun 5, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 17.2 years ago
Interventions
CTGel/ BPO Washdrug
Benzoyl Peroxide (BPO) wash will be used once daily in the morning for 28 days Clindamycin and Tretinoin (CT) gel will be used once daily in the evening for 28 days.
Soap Free Cleanser and CTGeldrug
Soap Free Cleanser will be used once daily in the morning for 28 days Clindamycin and Tretinoin gel will be used once daily in the evening for 28 days.